Where the World's First Antisense Clinic Began
And healing changed forever
Discover the World’s First Antisense Gene Therapy Clinic
Showcased at the World Expo Thailand Pavilion (WETP)
At Immunic, we do more than treat disease — we correct it at the source.
Through Antisense-based Gene Therapy, we silence faulty genetic messages that trigger inflammation and chronic illness. It's a breakthrough that's already healing people, strengthening animals without antibiotics, and supporting agriculture without chemicals.
Because health isn't just human — it's shared. And when we heal the code, we heal the system.
Genetic Precision
We silence faulty genetic messages that trigger inflammation and chronic illness.
Comprehensive Health
Healing people, strengthening animals without antibiotics, and supporting agriculture without chemicals.
Systemic Healing
Because health isn't just human — it's shared. When we heal the code, we heal the system.
This is more than medicine. It's a message:
The body isn't broken. It just needs the right instructions.
We have found the answer.
And now, we share it with the world.
Immunic — where healing begins at the source.
Antisense-based Gene Therapy
Silencing Faulty mRNA
Antisense-based Gene Therapy represents a significant advancement in precision medicine, targeting disease at the molecular level. Unlike conventional treatments that address proteins after they're formed, ABI intervenes earlier in the process by silencing faulty messenger RNA (mRNA).
The technology works by introducing synthetic antisense oligonucleotides (ASOs) that bind specifically to complementary sequences on target mRNA. This binding creates RNA-DNA hybrids that are recognized by RNase H enzymes, which then cleave the RNA strand, effectively preventing the translation of disease-causing proteins.
Precise Targeting
Affects only specific RNA sequences
High Efficacy
Achieves >90% silencing in clinical studies
Antisense-based Gene Therapy: Healing at the Root
At Immunic, we use cutting-edge RNA technology to silence harmful inflammation before it begins. Antisense molecules bind to faulty mRNA — preventing disease at the genetic level, safely and precisely.
Precision technology that targets specific RNA sequences without affecting healthy cells.
Designed to work at the root cause with minimal systemic side effects.
Built on decades of RNA research and cutting-edge therapeutic discoveries.
One Technology – One Health – One World
A breakthrough in treating inflammation at its source
In a world increasingly challenged by chronic disease, antibiotic resistance, and environmental stress, a new class of biotechnology is redefining how we treat inflammation — not by masking symptoms, but by correcting the source.
This is not simply another drug. This is a new therapeutic platform: Antisense-based Gene Therapy.
At its core is Immugence, a next-generation therapy that silences faulty genetic instructions (mRNA) responsible for chronic inflammation. Unlike conventional treatments that act downstream, Immugence intervenes upstream — at the level of molecular code — before damage takes place.
What makes this platform unique is its cross-species applicability. Antisense-based gene therapy is showing promise across human, veterinary, and agricultural health. In humans, Immugence is being used to address conditions including autoimmune diseases, acid reflux, kidney disorders, and spike-protein-related inflammation. In animals, its counterpart MaxBoost promotes resilience and reduces infection — without relying on antibiotics. In agriculture, similar principles are being applied to enhance plant immunity without chemical overuse.
This approach reflects a broader vision:
One Technology that addresses biological dysfunction at its genetic origin.
One Health that integrates human, animal, and environmental wellbeing.
One World where a unified platform can adapt across systems to drive scalable, sustainable health outcomes.
Read Full Editorial
Access the complete article to learn more about this groundbreaking technology.
Promising applications in treating chronic inflammatory conditions in humans.
Revolutionary treatments for companion and livestock animals.
Enhancing crop resilience and sustainability in agriculture.
Why Choose Immunic?
Safe and non-toxic
Our formulations are designed to be gentle on your body while effectively targeting pathogens.
Fast-acting at the molecular root
Our treatments work quickly by targeting the root cause at the molecular level.
Science-based, RNA-level precision
Advanced technology that targets specific RNA sequences with unparalleled precision.
Developed by leading Thai researchers
Created by a team of renowned scientists with extensive expertise in immunology.
Ready to take the next step?
Visit our clinic or explore more at our main site.
Scan to connect via LINE
What We Treat
We Treat What Others Can't
From neurodegeneration to chronic inflammation — we focus on conditions once thought untouchable.
Advanced treatments for various cancer types
Innovative solutions for kidney disease
Cutting-edge mental health treatments
Breakthrough approaches to cognitive decline
Novel therapies for movement disorders